Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis
Nuffield Health · National Health and Medical Research Council
Abstract
SummaryBackground Previous meta-analyses of summary data from randomised controlled trials have shown that statin therapy increases the risk of diabetes, but less is known about the size or timing of this effect, or who is at greatest risk. We aimed to address these gaps in knowledge through analysis of individual participant data from large, long-term, randomised, double-blind trials of statin therapy. Methods We conducted a meta-analysis of individual participant data from randomised controlled trials of statin therapy that participated in the CTT Collaboration. All double-blind randomised controlled trials of statin therapy of at least 2 years' scheduled duration and with at least 1000 participants were…
Citation impact
- FWCI
- 67.36
- Percentile
- 100%
- References
- 49
Authors
132- CRChristina ReithCorresponding
Nuffield Health, National Health and Medical Research Council
- DPDavid Preiss
Nuffield Health, National Health and Medical Research Council
- LBLisa Blackwell
Nuffield Health, National Health and Medical Research Council
- JEJonathan Emberson
Nuffield Health, National Health and Medical Research Council
- ESEnti Spata
Nuffield Health, National Health and Medical Research Council
Topics & keywords
- Medicine
- Statin
- Diabetes mellitus
- Meta-analysis
- Physical therapy
- Medical diagnosis
- Internal medicine
- Endocrinology
Funding
- UDU.S. Department of Veterans Affairs
- ALAbbott Laboratories
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- BABrigham and Women's Hospital
- FFibroGen
- CBCSL Behring
- SASouth Australian Health and Medical Research Institute
- RPRegeneron Pharmaceuticals
- WTWellcome TrustAward: CH/1996001/9454
- ITIntarcia Therapeutics
- MCMedicines Company
- KCKowa Company
- MMylan
- MModerna
- ZBZora Biosciences
- AAbiomed
- ABARCA Biopharma
- CRCancer Research UKAward: CH/1996001/9454
- NINational Institute for Health and Care ResearchAward: 17/140/02
- BHBritish Heart FoundationAwards: CH/1996001/9454, PG/18/16/33570
- UOUniversity of Oxford
- ESEuropean Society of Cardiology
- DDaiichi-Sankyo
- EEisai
- NNNovo Nordisk
- SServier
- STSilence Therapeutics
- ETEsperion Therapeutics
- NINational Institutes of Health
- ARAmerican Regent
- MRMedical Research CouncilAwards: CH/1996001/9454, MC_UU_00017/4, MC_UU_00017/4
- NHNational Health and Medical Research CouncilAwards: GNT1150467, GNT1037786
- JRJanssen Research and Development